Tumor-promoting immune cells are recruited to hypoxic regions in solid tumors owing to the secretion of chemotactic factors, such as colony stimulating factor 1 (CSF1) or vascular endothelial growth factor (VEGF), by hypoxic tumor cells. The gene discussed is CSF1; the disease is neoplasm.